Skip to main content
. 2004 Jan;6(1):1–6. doi: 10.1016/s1476-5586(04)80047-2

Figure 1.

Figure 1

ERBB2 (Her2/neu) gene centric expression analysis as revealed by ONCOMINE. (A) ERBB2 is overexpressed in a subset of breast cancers relative to normal breast tissue (P = .0567). (B) ERBB2 is significantly overexpressed in DLBCL relative to normal blood B-cells (P = 1.2e-6), in non small cell lung cancer relative to normal lung (P = 1.1e-5), and in ovarian carcinoma relative to normal ovary (P = 1.0e-5), but not in hepatocellular carcinoma or prostate cancer relative to their respective normal tissue. Y-axis units are normalized expression values (standard deviations above or below the median per array). The number of samples in each class is given in parentheses. Adenoca. indicates adenocarcinoma; Ca. indicates carcinoma; DLBCL indicates diffuse large B-cell lymphoma.